Sucampo Pharma (SCMP) Tops Q4 EPS by 3c

March 4, 2015 6:32 AM EST

Sucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.21, $0.03 better than the analyst estimate of $0.18. Revenue for the quarter came in at $37.8 million versus the consensus estimate of $37.23 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings